Authors Identify Monoclonal Antibody to Selectively Target CALR Mutations in MPNs
Studies Highlight Prognostic Value of Neutrophil-to-Lymphocyte Ratio in MPNs
Lower Pharmacy Costs Give Ruxolitinib Edge for Patients With MF and Anemia
Age, Race, Insurance Status Can Predict CV Mortality for Those With MPNs
The Importance of Symptomatic Improvement in MPN
Treatment Differences for Younger vs Older Patients With MPNs
New Data Challenge Traditional Treatment Paradigm in MPNs, Says Dr Raajit Rampal
Dr Raajit Rampal Discusses Disease Modification and Emerging Therapies in Polycythemia Vera
Emerging Data Continue to Evolve Treatment Utilization in MPNs
Dr Raajit Rampal Highlights Emerging Therapies in MPNs
Dr Jennifer Vaughn: Patients With MPN, MDS Should Discuss Long-Term Priorities Upfront
NCCN Guidelines for MPN Reflect New Drugs, Focus on Clinical Trials
Korean Study Finds DOAC Use “Seems Effective” in Patients With MPNs
Review Explores Cardiovascular Risk in Certain Patients With MPNs